跳至主要内容
临床试验/NCT00395408
NCT00395408已完成4 期

A Multicenter, Double-Blind, Randomized, Parallel-Group Study Comparing the Effect on Linear Growth of Montelukast With Placebo and Inhaled Beclomethasone in Pediatric Patients (Prepubertal, Tanner Stage I) With Mild Asthma

Organon and Co0 个研究点目标入组 360 人开始时间: 2000年6月最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
360
主要终点
To establish the difference in the average rate of linear growth over the 56-week double-blind treatment period between the montelukast and placebo groups

研究概览

简要总结

The purpose of this study is to compare the effect of montelukast with placebo and beclomethasone on the average rate of linear growth over a period of 56 weeks in children with mild asthma.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
6 Years 至 8 Years(Child)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

To establish the difference in the average rate of linear growth over the 56-week double-blind treatment period between the montelukast and placebo groups

次要结局

  • Discontinuations due to asthma
  • Peripheral blood eosinophil count
  • Oral corticosteroid rescues for asthma
  • Markers of bone turn-over
  • To evaluate the effects of montelukast in comparison with placebo and beclomethasone on FEV1
  • Beta-agonist use

研究者

申办方类型
Industry
责任方
Sponsor

相似试验